"An Page 384 and 385: doi:10.1016/j.trac.2009.02.006
Tirzepatide is a groundbreaking medication initially developed to manage type 2 diabetes, much like Semaglutide
This can lead to reduced cravings and withdrawal symptoms, making the recovery process more manageable
The company previously announced a new distribution partnership in Canada with Minogue Medical, a leading Canadian medical device company specialising in obesity care with a national ecosystem of dietitians, bariatric surgeons, and endoscopic specialists that is developing new standards of care in obesity in combination with GLP-1 therapy
And then if you think about affordability remaining challenged, lending standards themselves remaining tight, inventory remaining as low as it is, you could argue that we're at one of the more difficult times that we've seen for renters to exit rentership and step into homeownership
10.3389/fragi.2023.1161565 3 AtaullakhanovF